Urology department

The Institut Bordet Urology Department treats :

• prostate conditions:
  • diagnosis of all prostate diseases
  • treatment of benign prostate hypertrophia
  • refinement (diagnosis) of prostate cancers via different examinations including biopsies conducted on an out-patient basis and under local anaesthesia
  • hormone treatments
  • surgical treatments mainly via robotic surgery
  • focused ultrasound prostate treatment.
     
• Bladder conditions:
  • treatment of incontinence problems (surgery, rehabilitation, urodynamic testing, etc)
  • treatment of common bladder infections (for example, cystitis)
  • diagnosis and treatment of bladder polyps (via fluorescent light)
  • diagnosis and surgical treatment of malignant bladder tumours (cancers) with bladder reconstruction in cases of total organ ablation.

• Kidney and ureteral conditions:
  • diagnosis and treatment of infectious diseases of the kidney (pyelonephritis, for example), renal calculi (kidney stones), etc.
  • diagnosis and treatment of benign kidney tumours (cysts, for example)
  • diagnosis and treatment of malignant tumours (cancers) of the kidney
  • robotic surgery.
• Conditions affecting the male genitalia:
  • diagnosis and treatment of cancerous and non-cancerous tumours of the penis and testicles
  • laser treatment and sentinel node technique.

The Institut Bordet Urology Department is at the leading edge of fusion imaging, targeting and focused prostate cancer treatments (MRI – ultrasound – high frequency ultrasound).

Thanks to advances in medical imaging, in particular magnetic resonance imaging of the prostate, it is now possible to define suspect areas within the prostate. The Institut Bordet is the first centre to offer fusion imaging software. This software makes it possible to achieve very high precision guidance of the biopsies needed to characterise cancer. This fusion imaging is then exported in order to carry out focused treatment of the affected zones using high-energy ultrasound, thus allowing non-invasive, transrectal treatment of prostate cancer.